Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company Life Science Investing
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032 Life Science Investing
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b POSITIVE FIRST-LINE GASTRIC CANCER Life Science Investing
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology Pharmaceutical Investing
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance Pharmaceutical Investing
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline SmartNews
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia Geography
